Harvard Bioscience earnings were -$12.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest HBIO earnings report on Dec 31, 2024 announced Q4 2024 earnings of $18.0k, down 100.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HBIO reported annual earnings of -$12.4M, with 263.3% growth. The next HBIO earnings date is May 5, 2025.
What were Harvard Bioscience's earnings last quarter?
On HBIO's earnings call on Invalid Date, Harvard Bioscience (NASDAQ: HBIO) reported Q4 2024 earnings per share (EPS) of $0.01, up 125% year over year. Total HBIO earnings for the quarter were $18.00 thousand. In the same quarter last year, Harvard Bioscience's earnings per share (EPS) was -$0.04.
The next HBIO earnings date is Invalid Date. Add HBIO to your watchlist to be reminded of Harvard Bioscience's next earnings date.
Is Harvard Bioscience profitable or losing money?
As of the last Harvard Bioscience earnings report, Harvard Bioscience is currently losing money. Harvard Bioscience's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$12.41 million, a 263.25% increase year over year.
What was HBIO's earnings growth in the past year?
As of Harvard Bioscience's earnings date in Invalid Date, Harvard Bioscience's earnings has grown year over year. HBIO earnings in the past year totalled -$12.41 million.
What are Harvard Bioscience's earnings expectations?
The current EPS estimate for Harvard Bioscience's earnings report in Invalid Date is -$0.01.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.